Dupilumab treatment decreases MBC2s, correlating with reduced IgE levels in pediatric atopic dermatitis.

MLA

Starrenburg, Margot E., et al. “Dupilumab Treatment Decreases MBC2s, Correlating with Reduced IgE Levels in Pediatric Atopic Dermatitis.” Journal of Allergy & Clinical Immunology, vol. 154, no. 5, Nov. 2024, pp. 1333–13133. EBSCOhost, https://doi.org/10.1016/j.jaci.2024.06.023.

APA

Starrenburg, M. E., Bel Imam, M., Lopez, J. F., Buergi, L., Nguyen, N. T., Nouwen, A. E. M., Arends, N. J. T., Caspers, P. J., Akdis, M., Pasmans, S. G. M. A., & van de Veen, W. (2024). Dupilumab treatment decreases MBC2s, correlating with reduced IgE levels in pediatric atopic dermatitis. Journal of Allergy & Clinical Immunology, 154(5), 1333–13133. https://doi.org/10.1016/j.jaci.2024.06.023

Chicago

Starrenburg, Margot E., Manal Bel Imam, Juan F. Lopez, Laura Buergi, N. Tan Nguyen, Anouk E.M. Nouwen, Nicolette J.T. Arends, et al. 2024. “Dupilumab Treatment Decreases MBC2s, Correlating with Reduced IgE Levels in Pediatric Atopic Dermatitis.” Journal of Allergy & Clinical Immunology 154 (5): 1333–13133. doi:10.1016/j.jaci.2024.06.023.